More than £15 billion was wiped from AstraZeneca’s market value on Monday after reports that the pharmaceutical group has held talks over a potential US$400 billion merger with US rival
Share Talk Bulletin Board Heroes, Tuesday 30th July 2019
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this charting update.